Medical Supplies and Services News

Third-Quarter 2026 RevenueConference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, andMr GIORGIO IANNELLA, Head of Investor Relations,have the pleasure of inviting you to our...

Third-Quarter 2026 RevenueConference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, andMr GIORGIO IANNELLA, Head of Investor Relations,have the pleasure of inviting you to our...

Third-Quarter 2026 RevenueConference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, andMr GIORGIO IANNELLA, Head of Investor Relations,have the pleasure of inviting you to our...

Kylo Peptides has introduced a lifetime membership pricing program giving research buyers 50% off standard pricing on qualifying research products.

Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General...

Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement...

Dallas Neurosurgical & Spine doctors Jeremy Denning and Krishna Satyan are gearing up for World Spine Day, by providing tips for better back health.

Potentially accelerates development, assessment, and review for approval by FDA Sepsis impacts about 1.7 million U.S. adults annually and contributes to nearly one in three in-hospital deaths ...

Kylo Peptides has introduced a bulk research program for high-volume laboratories, with lot reservation & per-lot COAs from four independent laboratories.

Kylo Peptides review examines the supplier's lot-matched COAs, HPLC and LC-MS testing, and independent lab documentation for researchers.